¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific type"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
asthenic type
¹«·ÂüÇü
blood type
Ç÷¾×Çü
Borrmann type
º¸¸£¸¸Çü
Cowdry type A inclusion bodies
Ä«¿ìµå¸®AÇüÆ÷ÇÔü, Ä«¿ìµå¸®AÇüºÀÀÔü
Cowdry type B inclusion bodies
Ä«¿ìµå¸®BÇüÆ÷ÇÔü, Ä«¿ìµå¸®BÇüºÀÀÔü
delayed-type hypersensitivity
Áö¿¬°ú¹Î(¼º)
disorganized type schizophrenia
ºØ±«ÇüÁ¤½ÅºÐ¿º´
extroverted feeling type
¿ÜÇâÀû°¨Á¤Çü
extroverted type
¿ÜÇâÇü
enteropathy-type T-cell lymphoma
À庴ÁõÇüT¼¼Æ÷¸²ÇÁÁ¾
Golgi type I neuron
±äÃà»è½Å°æ¼¼Æ÷, °ñÁö1Çü½Å°æ¼¼Æ÷
Golgi type II neuron
ªÀºÃà»è½Å°æ¼¼Æ÷, °ñÁö2Çü½Å°æ¼¼Æ÷
hyperlipidemia type I
1Çü°íÁöÇ÷Áõ
hyperlipidemia type IV
4Çü°íÁöÇ÷Áõ
hyperlipidemia type V
5Çü°íÁöÇ÷Áõ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
13
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific gravity
ºñÁß
specific phobia
ƯÁ¤°øÆ÷(Áõ)
specific
ƯÀÌ-, ƯÁ¤-
tension type headache
±äÀåÇüµÎÅë
storage-type
ÃàÀûÇü
type
Çü, À¯Çü
blood type
Ç÷¾×Çü
Borrmann type
º¸¸£¸¸Çü
cellular type
¼¼Æ÷Çü
lepromatous type
³ªÁ¾Çü
scirrhous type
°æÈÇü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
type specific antigen
ÇüƯÀÌÇ׿ø
age-specific rate
¿¬·Éº°Æ¯¼öÀ²
age-specific death rate
¿¬·Éº°Æ¯¼ö»ç¸Á·ü
age-specific fertility rate
¿¬·Éº°Ãâ»êÀ²
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific action
ƯÀÌÀÛ¿ë
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific antagonist
ƯÀÌ´ëÇ×Á¦
specific antigen
ƯÀÌÇ׿ø
specific pathogen free animal
ƯÁ¤¹«º´¿øÃ¼µ¿¹°
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú
cause-specific rate
¿øÀκ°Æ¯¼öÀ²
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
SDA= specific dynamic action
ƯÀ̵¿Àû ÀÛ¿ë.
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
group-specific C carbohydrate
±ºÆ¯ÀÌ C ź¼öȹ°
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
group-specific antigen
±º-ƯÀÌÇ׿ø
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immunity, specific
ƯÀ̸鿪
platelet-specific antigens
Ç÷¼ÒÆÇƯÀÌÇ׿ø
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
specific type
ÇüƯÀ̼º(úþ÷åì¶àõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
type specific antigen
ÇüƯÀÌÇ׿ø
type specific polysaccharide
ÇüƯÀ̼º ´Ù´ç·ù(úþ÷åì¶àõÒýӨ׾).
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú.
bulk specific gravity
¿ëÀûºñÁß(é»îÝÝïñì)
donor-specific phage
°ø¿©±ÕƯÀÌÆÄÁö
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
group-specific C carbohydrate
±ºÆ¯ÀÌ C ź¼öȹ°
group-specific antigen
±º-ƯÀÌÇ׿ø
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½